Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.400
+0.060 (4.48%)
At close: Jun 18, 2026, 4:00 PM EDT
1.390
-0.010 (-0.71%)
After-hours: Jun 18, 2026, 7:52 PM EDT

PACB Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, PACB stock has a consensus rating of "Buy" and an average price target of $2.46. The average 1-year stock price forecast is 75.71% higher than the current stock price, while the lowest is $1.50 (+7.14%) and the highest is $3.00 (+114.29%).

Price Target: $2.46 (+75.71%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$1.50$2.46$2.63$3.00
Change+7.14%+75.71%+87.86%+114.29%
* Price targets were last updated on May 11, 2026.

Analyst Ratings

The average analyst rating for PACB stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy444444
Buy000000
Hold553332
Sell001111
Strong Sell000000
Total998887

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Sell
Reiterates
$1$1.5
SellReiterates$1$1.5+7.14%May 11, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$3
BuyReiterates$3+114.29%May 8, 2026
Piper Sandler
Piper Sandler
Hold
Reiterates
$2
HoldReiterates$2+42.86%May 8, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$3
BuyReiterates$3+114.29%May 8, 2026
Guggenheim
Guggenheim
Hold
Maintains
n/a
HoldMaintainsn/an/aFeb 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
167.82M
from 160.01M
Increased by 4.88%
Revenue Next Year
193.83M
from 167.82M
Increased by 15.50%
EPS This Year
-0.51
from -0.53
EPS Next Year
-0.40
from -0.51
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
130.51M128.30M200.52M154.01M160.01M167.82M
Revenue Growth
65.43%-1.69%56.29%-23.19%3.89%4.88%
Gross Profit
59.17M53.47M58.20M47.67M54.85M69.77M
Gross Margin
45.33%41.68%29.02%30.95%34.28%41.58%
Operating Income
-178.16M-304.82M-310.37M-290.66M-551.66M-133.45M
Net Income
-181.22M-314.25M-306.74M-309.85M-546.38M-128.57M
EPS
-----0.53-0.51
Free Cash Flow
-24.54M46.50M-311.67M-95.64M97.55M-101.90M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High171.0M
Avg167.8M
Low165.0M

Revenue Growth

Revenue Growth202620272028
High
6.9%
Avg
4.9%
Low
3.1%

EPS Forecast

EPS202620272028
High-0.49
Avg-0.51
Low-0.52

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-